Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Kidney International Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024925001792 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849434093072154624 |
|---|---|
| author | Roberto Pecoits-Filho, MD, PhD Michelle M.Y. Wong, MD Monica Moorthy, MSc Debasish Banerjee, MD Suman Behera, MD, FRCPC Viviane Calice-Silva, MD, PhD Mogamat-Yazied Chothia, PhD Gates B. Colbert, MD Martha Gulati, MD, MS Charles A. Herzog, MD Fadi Jouhra, MD Edgar V. Lerma, MD Charu Malik, PhD Kershaw V. Patel, MD Amina Rakisheva, MD Giuseppe M.C. Rosano, MD, PhD Priyanka Satish, MD Henry H.L. Wu, MBChB Angela Yee-Moon Wang, MD, PhD |
| author_facet | Roberto Pecoits-Filho, MD, PhD Michelle M.Y. Wong, MD Monica Moorthy, MSc Debasish Banerjee, MD Suman Behera, MD, FRCPC Viviane Calice-Silva, MD, PhD Mogamat-Yazied Chothia, PhD Gates B. Colbert, MD Martha Gulati, MD, MS Charles A. Herzog, MD Fadi Jouhra, MD Edgar V. Lerma, MD Charu Malik, PhD Kershaw V. Patel, MD Amina Rakisheva, MD Giuseppe M.C. Rosano, MD, PhD Priyanka Satish, MD Henry H.L. Wu, MBChB Angela Yee-Moon Wang, MD, PhD |
| author_sort | Roberto Pecoits-Filho, MD, PhD |
| collection | DOAJ |
| format | Article |
| id | doaj-art-de07a2f136b34db3b92467bb35e66d1b |
| institution | Kabale University |
| issn | 2468-0249 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-de07a2f136b34db3b92467bb35e66d1b2025-08-20T03:26:48ZengElsevierKidney International Reports2468-02492025-07-011072081208710.1016/j.ekir.2025.03.036Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney CommunityRoberto Pecoits-Filho, MD, PhD0Michelle M.Y. Wong, MD1Monica Moorthy, MSc2Debasish Banerjee, MD3Suman Behera, MD, FRCPC4Viviane Calice-Silva, MD, PhD5Mogamat-Yazied Chothia, PhD6Gates B. Colbert, MD7Martha Gulati, MD, MS8Charles A. Herzog, MD9Fadi Jouhra, MD10Edgar V. Lerma, MD11Charu Malik, PhD12Kershaw V. Patel, MD13Amina Rakisheva, MD14Giuseppe M.C. Rosano, MD, PhD15Priyanka Satish, MD16Henry H.L. Wu, MBChB17Angela Yee-Moon Wang, MD, PhD18Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA; Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Correspondence: Roberto Pecoits-Filho, MD, PhD, Arbor Research Collaborative for Health, 3989 Research Park Drive, Ann Arbor, MI 48108, USA.Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaInternational Society of Nephrology, Brussels, BelgiumRenal and Transplantation Unit, St George’s University Hospitals NHS Foundation Trust, Molecular and Clinical Sciences Research Institute, St George’s University of London, London, UKDivision of Nephrology, Southlake Regional Health and Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, CanadaResearch Department, Pro-rim Foundation and School of Medicine, UNIVILLE, Joinville-SC, BrazilDivision of Nephrology, Department of Medicine, Stellenbosch University, Cape Town, South AfricaDepartment of Nephrology, Texas A&M College of Medicine, Dallas, Texas, USABarbra Streisand Women’s Heart Center, Department of Cardiology, Cedars Sinai Heart Institute, Los Angeles, California, USACardiology Division, Dept. of Medicine, Hennepin Healthcare/University of Minnesota, Minneapolis, Minnesota, USACardiology Department, St George's University Hospitals NHS Foundation Trust, Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UKUniversity of Illinois at Chicago/ Advocate Christ Medical Center, Oak Lawn, Illinois, USAInternational Society of Nephrology, Brussels, BelgiumDepartment of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USACardiology Department, Scientific Research Institute of Cardiology and Internal Medicine, Almaty, KazakhstanCentre for Clinical and Basic Research, IRCCS San Raffaele, Rome, ItalyCenter for Cardiovascular Prevention, Ascension Texas Cardiovascular, Dell School of Medicine, Austin, Texas, USARenal Research, Kolling Institute of Medical Research, Royal North Shore Hospital & The University of Sydney, Sydney, AustraliaDepartment of Renal Medicine, Singapore General Hospital, Duke-National University of Singapore (NUS) Academic Medical Center, Singaporehttp://www.sciencedirect.com/science/article/pii/S2468024925001792Renin angiotensin aldosterone inhibitorschronic kidney diseaseheart failure |
| spellingShingle | Roberto Pecoits-Filho, MD, PhD Michelle M.Y. Wong, MD Monica Moorthy, MSc Debasish Banerjee, MD Suman Behera, MD, FRCPC Viviane Calice-Silva, MD, PhD Mogamat-Yazied Chothia, PhD Gates B. Colbert, MD Martha Gulati, MD, MS Charles A. Herzog, MD Fadi Jouhra, MD Edgar V. Lerma, MD Charu Malik, PhD Kershaw V. Patel, MD Amina Rakisheva, MD Giuseppe M.C. Rosano, MD, PhD Priyanka Satish, MD Henry H.L. Wu, MBChB Angela Yee-Moon Wang, MD, PhD Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community Kidney International Reports Renin angiotensin aldosterone inhibitors chronic kidney disease heart failure |
| title | Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community |
| title_full | Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community |
| title_fullStr | Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community |
| title_full_unstemmed | Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community |
| title_short | Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community |
| title_sort | optimization of renin angiotensin aldosterone inhibitor therapies for evidence based indications a call to action from the cardio kidney community |
| topic | Renin angiotensin aldosterone inhibitors chronic kidney disease heart failure |
| url | http://www.sciencedirect.com/science/article/pii/S2468024925001792 |
| work_keys_str_mv | AT robertopecoitsfilhomdphd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT michellemywongmd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT monicamoorthymsc optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT debasishbanerjeemd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT sumanbeheramdfrcpc optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT vivianecalicesilvamdphd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT mogamatyaziedchothiaphd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT gatesbcolbertmd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT marthagulatimdms optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT charlesaherzogmd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT fadijouhramd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT edgarvlermamd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT charumalikphd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT kershawvpatelmd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT aminarakishevamd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT giuseppemcrosanomdphd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT priyankasatishmd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT henryhlwumbchb optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT angelayeemoonwangmdphd optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity |